SUSTAINED RELEASE DELIVERY OF REPAGLINIDE BY BIODEGRADABLE MICROSPHERES

Journal Title: Journal of Drug Delivery and Therapeutics - Year 2017, Vol 7, Issue 7

Abstract

The primary objective of the present study was to prepare repaglinide microspheres for the sustained delivery of the drug for better patient care in the management of diabetics. The biodegradable microspheres of repaglinide is prepare using poly (lactic-co-glycolic acid) (PLGA) by emulsion solvent evaporation technique. The microspheres are prepared with different drug-to-carrier ratios and considering other variables (i.e. solvent, surfactant and stirrer speed) as well. The evaluation of microspheres prepared are perform on the basis of various parameters like particle size, percentage yield, drug entrapment efficiency, surface morphology, drug-polymer interaction (FT-IR study), in vitro drug release kinetics and stability studies. SEM reveals that microspheres are spherical and has nearly smooth surface morphology. The percentage yield and drug entrapment efficiency is quite well for all the formulations. FT-IR spectra show that there is no chemical interaction between the drug and the polymer. The in vitro release study data shows that the repaglinide release from all the formulations are slow and sustained upto 7days. The various kinetic equations indicate that the in vitro drug release is of zero order release with initial burst from repaglinide microspheres. There is no appreciable difference is observed in the stability study observations.

Authors and Affiliations

Gajanan Engla

Keywords

Related Articles

PRESCRIBERS` ADHERENCE TO BASIC PRESCRIPTION WRITING IN REFERRAL HOSPITALS IN ETHIOPIAN: THE CASE OF AYDER REFERRAL HOSPITAL

Background: Though there is no global standard for prescription writing, all prescriptions are fundamentally required to contain some basic elements and failure to include these can cause medication errors and poor treat...

FORMULATION, DEVELOPMENT AND CHARACTERIZATION OF SOLID LIPID NANOPARTICLES OF GEMCITABINE HYDROCHLORIDE

Gemcitabine Hydrochloride is a BCS class III drug of choice in the treatment of cancer, as a single or in combination chemotherapy. However, its bioavailability is a major concern due to its short half-life. Solid lipid...

DISSOLUTION METHOD DEVELOPMENT WITH CHROMATOGRAPHIC METHOD FOR DETERMINATION OF DRUG RELEASE IN DISSOLUTION SAMPLES OF URSODEOXYCHOLIC ACID TABLETS.

Ursodeoxycholic Acid is used in the treatment of Liver disease. An accurate and robust invitro method is developed and validated for measurement of drug release in Ursodeoxycholic Acid tablets. HPLC method for quantifica...

ANTI-ARTHRITIC EVALUATION OF SOME TRADITIONALLY USED MEDICINAL PLANTS IN FCA INDUCED ARTHRITIS IN RATS

Aim of Study: The main of study is to evaluate the anti-arthritic activity of some Traditionally Used Medicinal Plants in FCA Induced Arthritis in Rats. Material & Methods: All the selected medicinal plants were extract...

FORMULATION AND EVALUATION OF DOCETAXEL TRIHYDRATE LOADED SELF-ASSEMBLED NANOCARRIERS FOR TREATMENT OF HER2 POSITIVE BREAST CANCER

Human Epidermal Growth Factor Receptor 2-positive (HER2-positive) breast cancer tend to be more aggressive among all breast cancers. Breast cancers with HER2 gene amplification or HER2 protein overexpression are called H...

Download PDF file
  • EP ID EP299116
  • DOI -
  • Views 68
  • Downloads 0

How To Cite

Gajanan Engla (2017). SUSTAINED RELEASE DELIVERY OF REPAGLINIDE BY BIODEGRADABLE MICROSPHERES. Journal of Drug Delivery and Therapeutics, 7(7), 77-80. https://europub.co.uk/articles/-A-299116